Extramammary Paget's disease (EMPD) is a rare cutaneous adenocarcinoma that typically manifests in areas with apocrine glands. Recent research has deepened our understanding of its molecular ... EurekAlert!: Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy The research article presents a comprehensive evaluation of the human epidermal growth factor receptor 2 (HER2) status in extramammary Paget disease (EMPD) and explores the therapeutic potential of ...

Understanding the Context

Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy ascopubs.org: Clinical significance of HER2 expression between primary tumors and metastatic lymph nodes in patients with extramammary Paget's disease. Clinical significance of HER2 expression between primary tumors and metastatic lymph nodes in patients with extramammary Paget's disease. ascopubs.org: Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate (ADC) therapy. Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate (ADC) therapy.

Key Insights

Los Angeles Times: Paget’s Disease: Diagnosis, Management, and Insights into the Breast (PDB) Paget’s disease of the breast is a rare kind of breast cancer that mostly affects the skin around the nipple. It happens in only a small number of breast cancer cases because it’s linked to certain ...